Should SEC Step In On Sick-CEO Issue?

Lugo, Denise
May 2004
Investment Dealers' Digest;5/17/2004, Vol. 70 Issue 20, p10
Trade Publication
Reports that investors are wondering whether the United States Securities and Exchange Commission should establish guidelines for the health status disclosure of chief executive officers (CEO) of public companies. CEO deaths that have affected those companies' stock prices in the short term; Analysts say they do not take a CEO's health into account when evaluating a company; Overarching principle of "material information" in federal securities law.


Related Articles

  • SEC Adopts CEO Pay Ratio Disclosure Rule. Cohn, Michael // Accountingtoday.com;8/5/2015, p1 

    The Securities and Exchange Commission has adopted a final rule requiring public companies to disclose the ratio of the compensation of their CEOs to the median compensation of their employees.

  • Rules on pay disclosure may boost D&O exposures. Roberts, Sally // Business Insurance;1/30/2006, Vol. 40 Issue 5, p1 

    The article focuses on the new disclosure rules proposed by the U.S. Securities and Exchange Commission (SEC) which aimed to provide more detailed information regarding executive compensation and the rationale behind it. The proposed disclosure changes mark the first time since 1992 that the SEC...

  • How to Grant Equity Compensation Awards: A Roadmap of Best Practices. Cammaker, Joshua R.; Carlin, Wayne M.; Chinn, Adam D.; Goldstein, Jeremy L.; Katzke, Michael S.; O'Brien, Jeannemarie // Venulex Legal Summaries;2006 Q4, p1 

    The article discusses the requirement under the executive compensation disclosure of the U.S. Securities and Exchange Commission (SEC) concerning granting equity compensation awards. The requirement calls for companies to include a description of their practices regarding the timing and pricing...

  • 'Dark' Days for Sequenom as Ax Falls on Top Executives. Boggs, Jennifer // BioWorld Today;9/30/2009, Vol. 20 Issue 188, p3 

    The article reports on the decline in share price of Sequenom Inc., a molecular diagnostic firm which has terminated five employees following a five-month investigation into allegations of mishandling of research test data and results. The shares of Sequenom have suffered a 39 percent decline....

  • More Boards Splitting the Chairman and CEO Roles. Davis, Stephen; Lukomnik, Jon // Compliance Week;Aug2011, Vol. 8 Issue 91, p48 

    The article focuses on the trend in Standard & Poor (S&P) 500 companies of splitting the roles of a chair and a chief executive officer (CEO). It states that the idea of the separation started in the wake of the Sarbanes-Oakley Act of 2002, wherein directors need someone to preside during their...

  • PERSISTENT DELIVERY FAILURES: NAKED SHORTING AND ITS IMPACT ON A STOCK'S PRICE. Neuenschwander, Chris; Ziegler, Paul // International Journal of Business, Accounting, & Finance;Fall2014, Vol. 8 Issue 2, p136 

    This study examines the relationship between naked short selling on publicly traded companies and negative cumulative abnormal return (CAR) incurred by stocks where a short seller fails to deliver the security needed to close the short position. Past research suggests that most failures to...

  • Companies can 'go public' by getting listed on pink sheets. Klein, ED // Hudson Valley Business Journal;8/23/2004, Vol. 15 Issue 17, p1 

    There are currently 19 public companies in the Hudson River Valley in New Jersey and New York whose stock is listed on what has come to be known as "pink sheets." The color has nothing to do with the state of the company, but was the color of the paper on which stock prices were printed daily...

  • OVERCOMPENSATING. Surowiecki, James // New Yorker;2/13/2006, Vol. 82 Issue 1, p54 

    The article comments on the proposed rules of the U.S. Securities and Exchange Commission requiring companies to issue statements disclosing CEO compensation packages. The proposed rules will require companies to disclose more about executives' perks and stock-option grants and about their...

  • SEC Approves NYSE Proposal. Whitley, J. // Internal Auditor;Feb2004, Vol. 61 Issue 1, p18 

    Deals with the approval of a governance structure for the New York Stock Exchange (NYSE) by the U.S. Securities and Exchange Commission. Separation of functions of the chairman of the board and chief executive officer; Responsibilities of the approved board for NYSE; Governance disclosures to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics